RO60_HUMAN - dbPTM
RO60_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RO60_HUMAN
UniProt AC P10155
Protein Name 60 kDa SS-A/Ro ribonucleoprotein
Gene Name TROVE2
Organism Homo sapiens (Human).
Sequence Length 538
Subcellular Localization Cytoplasm . Localized in cytoplasmic mRNP granules containing untranslated mRNAs.
Protein Description RNA-binding protein that binds to misfolded non-coding RNAs, pre-5S rRNA, and several small cytoplasmic RNA molecules known as Y RNAs. May stabilize some of these RNAs and protect them from degradation.; May play roles in cilia formation and/or maintenance..
Protein Sequence MEESVNQMQPLNEKQIANSQDGYVWQVTDMNRLHRFLCFGSEGGTYYIKEQKLGLENAEALIRLIEDGRGCEVIQEIKSFSQEGRTTKQEPMLFALAICSQCSDISTKQAAFKAVSEVCRIPTHLFTFIQFKKDLKESMKCGMWGRALRKAIADWYNEKGGMALALAVTKYKQRNGWSHKDLLRLSHLKPSSEGLAIVTKYITKGWKEVHELYKEKALSVETEKLLKYLEAVEKVKRTRDELEVIHLIEEHRLVREHLLTNHLKSKEVWKALLQEMPLTALLRNLGKMTANSVLEPGNSEVSLVCEKLCNEKLLKKARIHPFHILIALETYKTGHGLRGKLKWRPDEEILKALDAAFYKTFKTVEPTGKRFLLAVDVSASMNQRVLGSILNASTVAAAMCMVVTRTEKDSYVVAFSDEMVPCPVTTDMTLQQVLMAMSQIPAGGTDCSLPMIWAQKTNTPADVFIVFTDNETFAGGVHPAIALREYRKKMDIPAKLIVCGMTSNGFTIADPDDRGMLDMCGFDTGALDVIRNFTLDMI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEESVNQM
-------CCCCCCCC
13.3922223895
4Phosphorylation----MEESVNQMQPL
----CCCCCCCCCCC
17.0423186163
19PhosphorylationNEKQIANSQDGYVWQ
CHHHHCCCCCCCEEE
22.1922167270
23PhosphorylationIANSQDGYVWQVTDM
HCCCCCCCEEEEECC
13.5522167270
41PhosphorylationHRFLCFGSEGGTYYI
EEEEEEECCCCEEEE
16.9021406692
45PhosphorylationCFGSEGGTYYIKEQK
EEECCCCEEEEEEEC
24.8221406692
46PhosphorylationFGSEGGTYYIKEQKL
EECCCCEEEEEEECC
13.3821406692
47PhosphorylationGSEGGTYYIKEQKLG
ECCCCEEEEEEECCC
12.8321406692
49 (in isoform 1)Ubiquitination-37.6621890473
49UbiquitinationEGGTYYIKEQKLGLE
CCCEEEEEEECCCCC
37.6621890473
49UbiquitinationEGGTYYIKEQKLGLE
CCCEEEEEEECCCCC
37.6621906983
49 (in isoform 2)Ubiquitination-37.6621906983
52UbiquitinationTYYIKEQKLGLENAE
EEEEEEECCCCCCHH
45.68-
69MethylationIRLIEDGRGCEVIQE
HHHHHCCCCCHHHHH
59.93115917861
78UbiquitinationCEVIQEIKSFSQEGR
CHHHHHHHHCCCCCC
44.70-
79PhosphorylationEVIQEIKSFSQEGRT
HHHHHHHHCCCCCCC
35.47-
113MethylationSTKQAAFKAVSEVCR
CHHHHHHHHHHHHHC
43.05115980489
138O-linked_GlycosylationFKKDLKESMKCGMWG
HCHHHHHHHCCCHHH
23.1929351928
140 (in isoform 1)Ubiquitination-36.5921890473
140UbiquitinationKDLKESMKCGMWGRA
HHHHHHHCCCHHHHH
36.5921906983
140 (in isoform 2)Ubiquitination-36.5921906983
140UbiquitinationKDLKESMKCGMWGRA
HHHHHHHCCCHHHHH
36.5921890473
170MalonylationALALAVTKYKQRNGW
HHHHHHHHHHHHCCC
43.8026320211
170AcetylationALALAVTKYKQRNGW
HHHHHHHHHHHHCCC
43.8025953088
170MethylationALALAVTKYKQRNGW
HHHHHHHHHHHHCCC
43.8030592659
180UbiquitinationQRNGWSHKDLLRLSH
HHCCCCHHHHHHHHC
44.55-
186PhosphorylationHKDLLRLSHLKPSSE
HHHHHHHHCCCCCCC
21.9723312004
189UbiquitinationLLRLSHLKPSSEGLA
HHHHHCCCCCCCCHH
37.1121906983
189 (in isoform 1)Ubiquitination-37.1121890473
189UbiquitinationLLRLSHLKPSSEGLA
HHHHHCCCCCCCCHH
37.1121890473
191PhosphorylationRLSHLKPSSEGLAIV
HHHCCCCCCCCHHHH
39.1620873877
192PhosphorylationLSHLKPSSEGLAIVT
HHCCCCCCCCHHHHH
44.1820873877
199PhosphorylationSEGLAIVTKYITKGW
CCCHHHHHHHHHCCH
16.4123312004
201PhosphorylationGLAIVTKYITKGWKE
CHHHHHHHHHCCHHH
12.4018491316
203PhosphorylationAIVTKYITKGWKEVH
HHHHHHHHCCHHHHH
22.0318491316
207UbiquitinationKYITKGWKEVHELYK
HHHHCCHHHHHHHHH
59.53-
213PhosphorylationWKEVHELYKEKALSV
HHHHHHHHHHHCCCC
17.7029083192
214AcetylationKEVHELYKEKALSVE
HHHHHHHHHHCCCCC
66.4225953088
214UbiquitinationKEVHELYKEKALSVE
HHHHHHHHHHCCCCC
66.42-
2162-HydroxyisobutyrylationVHELYKEKALSVETE
HHHHHHHHCCCCCHH
50.94-
219PhosphorylationLYKEKALSVETEKLL
HHHHHCCCCCHHHHH
23.8329255136
222PhosphorylationEKALSVETEKLLKYL
HHCCCCCHHHHHHHH
35.94-
224 (in isoform 1)Ubiquitination-67.5521890473
224UbiquitinationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5521890473
224UbiquitinationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5521890473
224UbiquitinationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5521890473
224UbiquitinationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5521890473
224UbiquitinationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5521890473
224UbiquitinationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5521890473
224AcetylationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.5519608861
2242-HydroxyisobutyrylationALSVETEKLLKYLEA
CCCCCHHHHHHHHHH
67.55-
227UbiquitinationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2221890473
227UbiquitinationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2221890473
227 (in isoform 1)Ubiquitination-59.2221890473
227UbiquitinationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2221890473
227UbiquitinationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2221890473
227UbiquitinationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2221890473
227UbiquitinationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2221890473
227AcetylationVETEKLLKYLEAVEK
CCHHHHHHHHHHHHH
59.2225953088
234UbiquitinationKYLEAVEKVKRTRDE
HHHHHHHHHHCCHHH
46.59-
236UbiquitinationLEAVEKVKRTRDELE
HHHHHHHHCCHHHHH
60.15-
264UbiquitinationHLLTNHLKSKEVWKA
HHHHHHHCCHHHHHH
52.51-
266UbiquitinationLTNHLKSKEVWKALL
HHHHHCCHHHHHHHH
55.49-
276SulfoxidationWKALLQEMPLTALLR
HHHHHHHCCHHHHHH
1.8130846556
279PhosphorylationLLQEMPLTALLRNLG
HHHHCCHHHHHHHHC
14.91-
287UbiquitinationALLRNLGKMTANSVL
HHHHHHCCCCCCCCC
35.92-
287MalonylationALLRNLGKMTANSVL
HHHHHHCCCCCCCCC
35.9226320211
307UbiquitinationEVSLVCEKLCNEKLL
HHHHHHHHHHCHHHH
53.89-
307AcetylationEVSLVCEKLCNEKLL
HHHHHHHHHHCHHHH
53.8926051181
312MalonylationCEKLCNEKLLKKARI
HHHHHCHHHHHHCCC
45.1626320211
312UbiquitinationCEKLCNEKLLKKARI
HHHHHCHHHHHHCCC
45.16-
312AcetylationCEKLCNEKLLKKARI
HHHHHCHHHHHHCCC
45.1623749302
342UbiquitinationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6421890473
342UbiquitinationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6421890473
342 (in isoform 1)Ubiquitination-44.6421890473
342UbiquitinationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6421890473
342UbiquitinationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6421890473
342UbiquitinationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6421890473
342AcetylationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6425953088
342UbiquitinationHGLRGKLKWRPDEEI
CCCCCCCCCCCCHHH
44.6421890473
359AcetylationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8219608861
359UbiquitinationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8221890473
359UbiquitinationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8221890473
359UbiquitinationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8221890473
359UbiquitinationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8221890473
359UbiquitinationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8221890473
359 (in isoform 1)Ubiquitination-40.8221890473
359UbiquitinationALDAAFYKTFKTVEP
HHHHHHHHHCCCCCC
40.8221890473
362UbiquitinationAAFYKTFKTVEPTGK
HHHHHHCCCCCCCCC
57.82-
3692-HydroxyisobutyrylationKTVEPTGKRFLLAVD
CCCCCCCCEEEEEEE
42.32-
393PhosphorylationLGSILNASTVAAAMC
HHHHHCHHHHHHHHH
23.4918452278
394PhosphorylationGSILNASTVAAAMCM
HHHHCHHHHHHHHHH
16.2618452278
503PhosphorylationLIVCGMTSNGFTIAD
EEEEECCCCCEEECC
26.5124114839
519 (in isoform 5)Phosphorylation-1.8020068231
524 (in isoform 5)Phosphorylation-23.3021406692
537SulfoxidationIRNFTLDMI------
HHHCCCCCC------
4.3930846556

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RO60_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RO60_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RO60_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RO52_HUMANTRIM21physical
10785401
LA_HUMANSSBphysical
10785401
TEP1_HUMANTEP1physical
22939629
SYCC_HUMANCARSphysical
22863883
GFPT1_HUMANGFPT1physical
22863883
HIRP3_HUMANHIRIP3physical
22863883
RL24_HUMANRPL24physical
22863883
SF01_HUMANSF1physical
22863883
XPO7_HUMANXPO7physical
22863883
ATLA3_HUMANATL3physical
26344197
TCP4_HUMANSUB1physical
26344197
QCR8_HUMANUQCRQphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RO60_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-224 AND LYS-359, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY.

TOP